Lv710
4040 积分 2022-09-05 加入
Validation of metastasis-free survival as a surrogate endpoint for overall survival in localized prostate cancer in the era of docetaxel for castration-resistant prostate cancer
1个月前
已完结
Neoadjuvant Novel Hormonal Therapy Followed by Prostatectomy versus Up-Front Prostatectomy for High-Risk Prostate Cancer: A Comparative Analysis
1个月前
已完结
Re-Evaluation of Pathologic Complete Response as a Surrogate for Event-Free and Overall Survival in Human Epidermal Growth Factor Receptor 2–Positive, Early Breast Cancer Treated With Neoadjuvant Therapy Including Anti–Human Epidermal Growth Factor Receptor 2 Therapy
1个月前
已完结
Artificial Intelligence and Pathomics
1个月前
已完结
Artificial intelligence applications in prostate cancer
1个月前
已完结
Artificial Intelligence in Oncology: Current Landscape, Challenges, and Future Directions
1个月前
已完结
The role of androgen deprivation therapy prior to radical prostatectomy in high-risk prostate cancer: a systematic review
1个月前
已完结
Neoadjuvant Novel Hormonal Therapy Followed by Prostatectomy versus Up-Front Prostatectomy for High-Risk Prostate Cancer: A Comparative Analysis
1个月前
已完结
Retzius Sparing Robot-Assisted Radical Prostatectomy Conveys Early Regain of Continence over Conventional Robot-Assisted Radical Prostatectomy: A Propensity Score Matched Analysis of 1,863 Patients
2个月前
已完结
Olaparib Without Androgen Deprivation for High-Risk Biochemically Recurrent Prostate Cancer Following Prostatectomy
2个月前
已完结
皖公网安备34019202002308
